BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhi YH, Liu RS, Song MM, Tian Y, Long J, Tu W, Guo RX. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 2005; 11(24): 3724-3728 [PMID: 15968728 DOI: 10.3748/wjg.v11.i24.3724]
URL: https://www.wjgnet.com/1007-9327/full/v11/i24/3724.htm
Number Citing Articles
1
Pablo Letelier, Patricia Garcia, Pamela Leal, Carmen Ili, Kurt Buchegger, Ismael Riquelme, Alejandra Sandoval, Oscar Tapia, Juan C. Roa. Immunohistochemical Expression of Vascular Endothelial Growth Factor A in Advanced Gallbladder CarcinomaApplied Immunohistochemistry & Molecular Morphology 2014; 22(7): 530 doi: 10.1097/PAI.0b013e3182a318a9
2
Bujung Hong, Makoto Nakamura, Joachim K. Krauss. Tumors of the Central Nervous System, Volume 13Tumors of the Central Nervous System 2014; 13: 41 doi: 10.1007/978-94-007-7602-9_5
3
Kyoung-Bun Lee. Histologic and Molecular Pathogenesis of Gallbladder CancerThe Korean Journal of Pancreas and Biliary Tract 2018; 23(1): 1 doi: 10.15279/kpba.2018.23.1.1
4
Takahiro Naruse, Yukihiro Matsuyama, Naoki Ishiguro. Cyclooxygenase-2 expression in ependymoma of the spinal cordJournal of Neurosurgery: Spine 2007; 6(3): 240 doi: 10.3171/spi.2007.6.3.240
5
E. M. Elia, D. Belgorosky, M. Faut, S. Vighi, C. Pustovrh, D. Luigi, A. B. Motta. The effects of metformin on uterine tissue of hyperandrogenized BALB/c miceMolecular Human Reproduction 2009; 15(7): 421 doi: 10.1093/molehr/gap033
6
Sanjeev K. Maurya, Mallika Tewari, Raghvendra R. Mishra, Hari S. Shukla. Genetic abberations in gallbladder cancerSurgical Oncology 2012; 21(1): 37 doi: 10.1016/j.suronc.2010.09.003
7
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_148-1
8
Yumin Li, Junqiang Zhang, Haizhen Ma. Chronic inflammation and gallbladder cancerCancer Letters 2014; 345(2): 242 doi: 10.1016/j.canlet.2013.08.034
9
Monika Vishnoi, Sachchida Nand Pandey, Dinesh Raj Modi, Ashok Kumar, Balraj Mittal. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor β1 -509C>T gene polymorphisms with gallbladder cancerHuman Immunology 2008; 69(6): 360 doi: 10.1016/j.humimm.2008.04.004
10
Munita Meenu Bal, Mukta Ramadwar, Kedar Deodhar, Shailesh Shrikhande. Pathology of Gallbladder Carcinoma: Current Understanding and New PerspectivesPathology & Oncology Research 2015; 21(3): 509 doi: 10.1007/s12253-014-9886-3
11
Manjusha Dixit, Vinay J, Soham Choudhury. Gallbladder Cancer2023; : 291 doi: 10.1007/978-981-19-6442-8_16
12
Elizabeth P. Ryan, Timothy P. Bushnell, Alan E. Friedman, Irfan Rahman, Richard P. Phipps. Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cellsCancer Immunology, Immunotherapy 2008; 57(3): 347 doi: 10.1007/s00262-007-0374-4
13
ZHE LONG LIANG, MEERAN KIM, SONG MEI HUANG, HYO JIN LEE, JIN-MAN KIM. Expression of carboxyl terminus of Hsp70-interacting protein (CHIP) indicates poor prognosis in human gallbladder carcinomaOncology Letters 2013; 5(3): 813 doi: 10.3892/ol.2013.1138
14
Claudia Bocca, Francesca Bozzo, Stefania Cannito, Maurizio Parola, Antonella Miglietta. Celecoxib inactivates epithelial–mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cellsMolecular Carcinogenesis 2012; 51(10): 783 doi: 10.1002/mc.20846
15
Hee Jung Kim, Ga Won Yim, Eun Ji Nam, Young Tae Kim. Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3Cancer Research and Treatment 2014; 46(1): 81 doi: 10.4143/crt.2014.46.1.81
16
Sung-Im Do, Gou Young Kim, Sung-Jig Lim, Youn Wha Kim. Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder CarcinomaThe Korean Journal of Pathology 2010; 44(1): 42 doi: 10.4132/KoreanJPathol.2010.44.1.42
17
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancerExpert Opinion on Emerging Drugs 2007; 12(4): 571 doi: 10.1517/14728214.12.4.571
18
Byung Hoon Kim, Chun Il Kim, Hyuk Soo Chang, Mi Sun Choe, Hye Ra Jung, Duk Yoon Kim, Choal Hee Park. Cyclooxygenase-2 Overexpression in Chronic Inflammation Associated with Benign Prostatic Hyperplasia: Is It Related to Apoptosis and Angiogenesis of Prostate Cancer?Korean Journal of Urology 2011; 52(4): 253 doi: 10.4111/kju.2011.52.4.253
19
Alphonse E Sirica. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaWorld Journal of Gastroenterology 2008; 14(46): 7033-7058 doi: 10.3748/wjg.14.7033
20
A. Giatromanolaki, E. Sivridis, C. Simopoulos, A. Polychronidis, K.C. Gatter, A.L. Harris, M.I. Koukourakis. Hypoxia inducible factors 1α and 2α are associated with VEGF expression and angiogenesis in gallbladder carcinomasJournal of Surgical Oncology 2006; 94(3): 242 doi: 10.1002/jso.20443
21
Helen P.S. Wong, Judy W.C. Ho, Marcel W.L. Koo, Le Yu, William K.K. Wu, Emily K.Y. Lam, Emily K.K. Tai, Joshua K.S. Ko, Vivian Y. Shin, Kent Man Chu, Chi Hin Cho. Effects of adrenaline in human colon adenocarcinoma HT-29 cellsLife Sciences 2011; 88(25-26): 1108 doi: 10.1016/j.lfs.2011.04.007
22
Seok‐Woo Park, Hyo‐Sun Kim, Jeong‐Hun Hah, Kwang‐Hyun Kim, Dae‐Seog Heo, Myung‐Whun Sung. Differential effects between cyclooxygenase‐2 inhibitors and siRNA on vascular endothelial growth factor production in head and neck squamous cell carcinoma cell linesHead & Neck 2010; 32(11): 1534 doi: 10.1002/hed.21362
23
Robert David Goldin, Juan Carlos Roa. Gallbladder cancer: a morphological and molecular updateHistopathology 2009; 55(2): 218 doi: 10.1111/j.1365-2559.2008.03192.x
24
Imran Khan, Monika Bhardwaj, Shruti Shukla, Hoomin Lee, Mi-Hwa Oh, Vivek K. Bajpai, Yun Suk Huh, Sun Chul Kang. Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma modelColloids and Surfaces B: Biointerfaces 2019; 181: 612 doi: 10.1016/j.colsurfb.2019.06.016
25
Armin Thelen, Arne Scholz, Wilko Weichert, Bertram Wiedenmann, Peter Neuhaus, Reinhard Geßner, Christoph Benckert, Sven Jonas. Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic CholangiocarcinomaAmerican Journal of Gastroenterology 2010; 105(5): 1123 doi: 10.1038/ajg.2009.674
26
Bujung Hong, Claudia A Krusche, Kerstin Schwabe, Sabrina Friedrich, Rüdiger Klein, Joachim K Krauss, Makoto Nakamura. Cyclooxygenase-2 Supports Tumor Proliferation in Vestibular SchwannomasNeurosurgery 2011; 68(4): 1112 doi: 10.1227/NEU.0b013e318208f5c7
27
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt, Andrej Cör. Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesionsWorld Journal of Gastroenterology 2006; 12(21): 3425-3429 doi: 10.3748/wjg.v12.i21.3425
28
Chih-Long Chang, Barbara Ma, Xiaowu Pang, T-C Wu, Chien-Fu Hung. Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian CancerMolecular Therapy 2009; 17(8): 1365 doi: 10.1038/mt.2009.118
29
Ki Won Lee, Joydeb Kumar Kundu, Sue Ok Kim, Kyung-Soo Chun, Hyong Joo Lee, Young-Joon Surh. Cocoa Polyphenols Inhibit Phorbol Ester-Induced Superoxide Anion Formation in Cultured HL-60 Cells and Expression of Cyclooxygenase-2 and Activation of NF-κB and MAPKs in Mouse Skin In VivoThe Journal of Nutrition 2006; 136(5): 1150 doi: 10.1093/jn/136.5.1150
30
Vivian Y. Shin, William K.K. Wu, Kent-Man Chu, Helen P.S. Wong, Emily K.Y. Lam, Emily K.K. Tai, Marcel W.L. Koo, Chi-Hin Cho. Nicotine Induces Cyclooxygenase-2 and Vascular Endothelial Growth Factor Receptor-2 in Association with Tumor-Associated Invasion and Angiogenesis in Gastric CancerMolecular Cancer Research 2005; 3(11): 607 doi: 10.1158/1541-7786.MCR-05-0106
31
C. Pepper, J. G. Mahdi, A. G. S. Buggins, S. Hewamana, E. Walsby, E. Mahdi, A. Al-Haza’a, A. J. Mahdi, T. T. Lin, L. Pearce, L. Morgan, I. D. Bowen, P. Brennan, C. Fegan. Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2Cell Proliferation 2011; 44(4): 380 doi: 10.1111/j.1365-2184.2011.00760.x
32
Mehmet ßahin, Emel ßahin, Saadet Gümüşlü. Cyclooxygenase-2 in Cancer and AngiogenesisAngiology 2009; 60(2): 242 doi: 10.1177/0003319708318378
33
Sharon Weber, William Jarnagin, Austin Duffy, Eileen M. O'Reilly, Ghassan K. Abou-Alfa, Leslie Blumgart. Abeloff's Clinical Oncology2008; : 1569 doi: 10.1016/B978-0-443-06694-8.50088-9
34
P. Baichan, P. Naicker, J. W. S. Devar, M. Smith, G. P. Candy, E. Nweke. Targeting gallbladder cancer: a pathway based perspectiveMolecular Biology Reports 2020; 47(3): 2361 doi: 10.1007/s11033-020-05269-x
35
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt. Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosisScandinavian Journal of Gastroenterology 2009; 44(9): 1101 doi: 10.1080/00365520903121685
36
Juan Carlos Roa, Nora Katabi, N. Volkan Adsay. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 891 doi: 10.1007/978-1-4419-7107-4_61
37
Eric I Marks, Nelson S Yee. Molecular genetics and targeted therapeutics in biliary tract carcinomaWorld Journal of Gastroenterology 2016; 22(4): 1335-1347 doi: 10.3748/wjg.v22.i4.1335
38
Alphonse E. Sirica, Zichen Zhang, Guan-Hua Lai, Toru Asano, Xue-Ning Shen, Deanna J. Ward, Arvind Mahatme, Jennifer L. DeWitt. A novel “patient-like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell linesHepatology 2007; 47(4): 1178 doi: 10.1002/hep.22088
39
Melanie B Thomas. Targeted therapies for cancer of the gallbladderCurrent Opinion in Gastroenterology 2008; 24(3): 372 doi: 10.1097/MOG.0b013e3282f6a7df
40
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2647 doi: 10.1007/978-3-319-26956-6_148